28 January 2025

Santella reaches top 3 in the Ypsomed Innovation Award 2025

Our warmest congratulations to Santella for being among the top 3 finalists at the Ypsomed Innovation Award 2025. Santella will receive CHF 25,000 from the Ypsomed Innovation Fund to develop its innovative vaccines.

Santella is a start-up led by Sabrina Stöckli, Olivier Schären and Siegfried Hapfelmeier at the University of Bern, with support from the NCCR from 2022 to 2024. In Switzerland and the world, bacterial infections are a major problem in livestock production, especially poultry. Sick animals are currently treated with antibiotics, with undesired negative effects such as the rise of antibiotic resistance. To circumvent this issue, Santella is developing live probiotic vaccines to fight disease caused by pathogenic enterobacteria without resorting to antibiotics. 

Photo credit: www.ypsomed.com
Photo credit: www.ypsomed.com